DrugLog®
Key features of DrugLog®
Reliable drug verification in seconds
Why DrugLog®
*DrugLog® is a registered trademark in EU and GB.
There is a need for simple quality control methods for individualized intravenous drugs that can be applied in the routine of a compounding unit and at the point of care. Innovative solutions have to be developed in collaboration between industrial companies and healthcare organizations. The results from the first technical and process validations of Pharmacolog’s product, DrugLog®, for cytostatic drugs at our department are promising. We will therefore continue the collaboration with Pharmacolog and evaluate the DrugLog® technology in the daily operation also for other drugs, and contribute to new technical developments in point of care solutions for individualized intravenous treatment control.
Prof. Pascal Bonnabry
Director Hospital Pharmacy, Hôpitaux Universitaires de Genève, Geneva, Swizerland
It is well known that drug preparation in surgical units is considered at high risk, due to the stress and the multifaceted activities of medical staff. The aim of the research project on the DrugLog® system is to investigate the possibility to secure in routine the drug preparation in surgical units. To achieve this goal, firstly, we will realize a qualification for 13 drugs, such as heparin, adrenaline and different antibiotics commonly used in surgery based on the recommendations of the French Society of Pharmaceutical Science and Technology. Secondly, this qualification assay step will be completed by a selectivity and robustness study with similar drugs. Finally, if the two first steps are positive, the DrugLog® system will be used in the surgical unit to evaluate its capacity in routine use and its ability to avoid drug errors: syringe switch, wrong drugs or concentration errors.
Prof. Pascal Odou